trending Market Intelligence /marketintelligence/en/news-insights/trending/4cXPxqbfzKHfcwmx57qUrQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

IDEXX Laboratories Q2 profit climbs 15.7% YOY; FY'19 outlook revised

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


IDEXX Laboratories Q2 profit climbs 15.7% YOY; FY'19 outlook revised

IDEXX Laboratories Inc. said its second-quarter net income attributable to stockholders came to $125.7 million, an increase of 15.7% from $108.7 million in the year-earlier period.

EPS climbed 16.3% year over year to $1.43 from $1.23.

The S&P Global Market Intelligence consensus normalized EPS estimate for the quarter is $1.37.

The Westbrook, Maine-based medical-device maker's revenue rose 6.8% yearly to $620.1 million from $580.8 million. Research and development expenses also rose 9.3% on an annual basis to $32.3 million from $29.5 million.

IDEXX revised its outlook for the full year, with EPS in the range of $4.82 to $4.92, up from previous guidance in the range of $4.76 to $4.88.

Meanwhile, the company lowered its revenue forecast to $2.38 billion to $2.41 billion, compared to its prior outlook of $2.39 billion to $2.43 billion, to reflect the impact of updated foreign exchange estimates and operational refinements for the second quarter.

The S&P Global Market Intelligence consensus normalized EPS estimate for 2019 is $4.83.